Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://molmed.org/journal/articles/3/1228 http://repositorio.unifesp.br/handle/11600/30985 |
Resumo: | Ischemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response. |
id |
UFSP_54d564dae7c662a1912891723b10ec9e |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/30985 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of FibrosisIschemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response.Universidade Federal de São Paulo, Div Nephrol, Expt & Clin Immunol Lab, São Paulo, BrazilUniv Fed Juiz de Fora, Div Nephrol, Juiz de Fora, MG, BrazilUniv Estadual Campinas, Div Nephrol, Campinas, SP, BrazilUniv Fed Triangulo Mineiro, Uberaba, MG, BrazilUniv São Paulo, Inst Biomed Sci 4, Dept Immunol, Transplantat Immunobiol Lab, BR-05508900 São Paulo, BrazilUniversidade Federal de São Paulo, Div Nephrol, Expt & Clin Immunol Lab, São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundacao de Amparo a Pesquisa of São PauloFundacao de Amparo a Pesquisa of São Paulo: 04/08311-4Fundacao de Amparo a Pesquisa of São Paulo: 04/13449-7Fundacao de Amparo a Pesquisa of São Paulo: 06/03982-5Fundacao de Amparo a Pesquisa of São Paulo: 07/07139-3Feinstein Inst Med ResUniversidade Federal de São Paulo (UNIFESP)Univ Fed Juiz de ForaUniversidade Estadual de Campinas (UNICAMP)Univ Fed Triangulo MineiroUniversidade de São Paulo (USP)Feitoza, Carla Q. [UNIFESP]Gonalves, Giselle M. [UNIFESP]Semedo, Patricia [UNIFESP]Cenedeze, Marcos A. [UNIFESP]Pinheiro, Helady S.Beraldo, Felipe CaetanoSantos, Oscar Fernando Pavao dos [UNIFESP]Teixeira, Vicente de Paula A.Reis, Marlene A. dosMazzali, MarildaPacheco-Silva, Alvaro [UNIFESP]Camara, Niels O. S. [UNIFESP]2016-01-24T13:51:49Z2016-01-24T13:51:49Z2008-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion724-730http://molmed.org/journal/articles/3/1228Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008.10.2119/2008-00064.Feitoza1076-1551http://repositorio.unifesp.br/handle/11600/30985WOS:000260980300008engMolecular Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2023-05-18T14:42:42Zoai:repositorio.unifesp.br/:11600/30985Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652023-05-18T14:42:42Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
title |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
spellingShingle |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis Feitoza, Carla Q. [UNIFESP] |
title_short |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
title_full |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
title_fullStr |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
title_full_unstemmed |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
title_sort |
Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis |
author |
Feitoza, Carla Q. [UNIFESP] |
author_facet |
Feitoza, Carla Q. [UNIFESP] Gonalves, Giselle M. [UNIFESP] Semedo, Patricia [UNIFESP] Cenedeze, Marcos A. [UNIFESP] Pinheiro, Helady S. Beraldo, Felipe Caetano Santos, Oscar Fernando Pavao dos [UNIFESP] Teixeira, Vicente de Paula A. Reis, Marlene A. dos Mazzali, Marilda Pacheco-Silva, Alvaro [UNIFESP] Camara, Niels O. S. [UNIFESP] |
author_role |
author |
author2 |
Gonalves, Giselle M. [UNIFESP] Semedo, Patricia [UNIFESP] Cenedeze, Marcos A. [UNIFESP] Pinheiro, Helady S. Beraldo, Felipe Caetano Santos, Oscar Fernando Pavao dos [UNIFESP] Teixeira, Vicente de Paula A. Reis, Marlene A. dos Mazzali, Marilda Pacheco-Silva, Alvaro [UNIFESP] Camara, Niels O. S. [UNIFESP] |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Univ Fed Juiz de Fora Universidade Estadual de Campinas (UNICAMP) Univ Fed Triangulo Mineiro Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Feitoza, Carla Q. [UNIFESP] Gonalves, Giselle M. [UNIFESP] Semedo, Patricia [UNIFESP] Cenedeze, Marcos A. [UNIFESP] Pinheiro, Helady S. Beraldo, Felipe Caetano Santos, Oscar Fernando Pavao dos [UNIFESP] Teixeira, Vicente de Paula A. Reis, Marlene A. dos Mazzali, Marilda Pacheco-Silva, Alvaro [UNIFESP] Camara, Niels O. S. [UNIFESP] |
description |
Ischemia and reperfusion injury (IRI) contributes to the development of chronic interstitial fibrosis/tubular atrophy in renal allograft patients, Cyclooxygenase (COX) 1 and 2 actively participate in acute ischemic injury by activating endothelial cells and inducing oxidative stress. Furthermore, blockade of COX I and 2 has been associated with organ improvement after ischemic damage. the aim of this study was to evaluate the role of COX I and 2 in the development of fibrosis by performing a COX I and 2 blockade immediately before IRI We subjected C57BI/6 male mice to 60 min of unilateral renal pedicle occlusion, Prior to surgery mice were either treated with indomethacin (IMT) at days -1 and 0 or were untreated. Blood and kidney samples were collected 6 wks after IRI. Kidney samples were analyzed by real-time reverse transcription-poly me rase chain reaction for expression of transforming growth factor beta (TGF-beta), monocyte chemoattractant protein 1 (MCP-1), osteopontin (OPN), tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-10, heme oxygenose 1 (HO-1), vimentin, connective-tissue growth factor (CTGF), collagen 1, and bone morphogenic protein 7 (BMP-7), To assess tissue fibrosis we performed morphometric analyses and Sirius red staining. We also performed immunohistochemical analysis of anti-actin smooth muscle, Renal function did not significantly differ between groups. Animals pretreated with IMT showed significantly less interstitial fibrosis than nontreated animals. Gene transcript analyses showed decreased expression of TGF-beta, MCP-1,TNF-alpha, IL-1-beta, vimentin, collagen 1, CTGF and IL-10 mRNA (all P < 0.05), Moreover, HO-I mRNA was increased in animals pretreated with IMT (P < 0.05) Conversely, IMT treatment decreased osteopontin expression and enhanced BMP-7 expression, although these levels did rot reach statistical significance when compared with control expression levels, I he blockade of COX 1 and 2 resulted in less tissue fibrosis, which was associated with a decrease in proinflammatory cytokines and enhancement of the protective cellular response. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-11-01 2016-01-24T13:51:49Z 2016-01-24T13:51:49Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://molmed.org/journal/articles/3/1228 Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008. 10.2119/2008-00064.Feitoza 1076-1551 http://repositorio.unifesp.br/handle/11600/30985 WOS:000260980300008 |
url |
http://molmed.org/journal/articles/3/1228 http://repositorio.unifesp.br/handle/11600/30985 |
identifier_str_mv |
Molecular Medicine. Manhasset: Feinstein Inst Med Res, v. 14, n. 11-12, p. 724-730, 2008. 10.2119/2008-00064.Feitoza 1076-1551 WOS:000260980300008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Molecular Medicine |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
724-730 |
dc.publisher.none.fl_str_mv |
Feinstein Inst Med Res |
publisher.none.fl_str_mv |
Feinstein Inst Med Res |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268348028944384 |